LeMaitre Vascular, Inc. (LMAT) Q3 2018 Earnings Results

Lemaitre Vascular Misses on Revenue, Stock Down 1.83%

The lack of revenue figures and guidance may raise concerns among investors about Lemaitre Vascular's future performance. The stock's decline of 1.83% reflects uncertainty in the market, as investors typically prefer clear guidance and strong revenue metrics. Without specific targets, the company may face challenges in maintaining investor confidence.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.21	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management emphasized the importance of operational stability. They did not offer specific guidance for future quarters, indicating a cautious approach.

Management did not provide specific revenue figures or guidance during the call.

The focus was on maintaining operational efficiency and market position.

Lemaitre Vascular Misses on Revenue, Stock Down 1.83%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular Misses on Revenue, Stock Down 1.83%

Key numbers

Management commentary